Stock Earnings

Question 1

What are iTeos Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), iTeos Therapeutics Inc has a total asset of $687, Net loss of $-134

Question 2

What are the key financial ratios for ITOS?

Accepted Answer

iTeos Therapeutics Inc's Current ratio is 7.08, has a Net margin is -382.85, sales per share of $0.86.

Question 3

How is iTeos Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

iTeos Therapeutics Inc largest revenue segment is Cancer Immunotherapies, at a revenue of 35,000,000 in the most earnings release.For geography, Belgium is the primary market for iTeos Therapeutics Inc, at a revenue of 35,000,000.

Question 4

Is iTeos Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, iTeos Therapeutics Inc has a net loss of $-134

Question 5

Does iTeos Therapeutics Inc have any liabilities?

Accepted Answer

yes, iTeos Therapeutics Inc has liability of 97

Question 6

How many outstanding shares for iTeos Therapeutics Inc?

Accepted Answer

iTeos Therapeutics Inc has a total outstanding shares of 37

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	35	12	267	344	0
Revenue Growth (YoY)	-100%	192%	-96%	-22%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	34	49	50	43	40	15
Research & Development	131	145	113	97	59	29
Operating Expenses	165	194	163	141	99	45
Other Non Operating Income (Expenses)	3	8	10	11	11	7
Pretax Income	-156	-120	-109	148	256	-38
Income Tax Expense	11	14	3	52	41	0
Net Income	-167	-134	-112	96	214	-43
Net Income Growth	55%	20%	-217%	-55%	-598%	65%
Shares Outstanding (Diluted)	43.56	40.47	35.76	37.8	37.8	35
Shares Change (YoY)	10%	13%	-5%	0%	8%	5%
EPS (Diluted)	-3.87	-3.32	-3.14	2.56	5.68	-1.24
EPS Growth	42%	5%	-223%	-55%	-558%	55%
Free Cash Flow	-108	-99	-106	-112	511	-25
Free Cash Flow Per Share	-2.47	-2.44	-2.96	-2.96	13.51	-0.71
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-454.28%	-1,258.33%	47.19%	70.93%	0%
Profit Margin	0%	-382.85%	-933.33%	35.95%	62.2%	0%
Free Cash Flow Margin	0%	-282.85%	-883.33%	-41.94%	148.54%	0%
EBITDA	-164	-158	-151	126	244	-45
EBITDA Margin	0%	-451.42%	-1,258.33%	47.19%	70.93%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	-165	-159	-151	126	244	-45
EBIT Margin	0%	-454.28%	-1,258.33%	47.19%	70.93%	0%
Effective Tax Rate	-7.05%	-11.66%	-2.75%	35.13%	16.01%	0%

iTeos Therapeutics Inc (ITOS) Price

ITOS Stock Price Chart

ITOS Income

Follow-Up Questions